Tiziana Life Sciences Ltd (TLSA) Stock Analysis
A live, multi-source view of Tiziana Life Sciences Ltd (TLSA): real-time price, technical indicators, Wall Street analyst consensus, recent news sentiment and social buzz — aggregated into one place so you can size up the stock at a glance.
About Tiziana Life Sciences Ltd
Tiziana Life Sciences Ltd, together with its subsidiaries, engages in the research and development of therapies for neurodegenerative and neuroinflammatory diseases in the United Kingdom and internationally. It develops Foralumab TZLS-401, a human anti-CD3 monoclonal antibody, which is Phase II clinical trial for the treatment of non-active secondary progressive multiple sclerosis, Alzheimer's disease, multi system atrophy, and amyotrophic lateral sclerosis; and TZLS-501, a human anti-IL-6R monoclonal antibody for the treatment of autoimmune and inflammatory diseases. The company is headquartered in London, the United Kingdom.
Sector: Healthcare · Industry: Biotechnology · United Kingdom · 10 employees · tizianalifesciences.com
Key statistics · as of 2026-09-06
As of 2026-09-06, Tiziana Life Sciences Ltd (TLSA) had a market capitalization of $129.8M (forward -5.1) and a beta of 0.45; the shares traded in a 52-week range of $0.87 – $2.35 (-37.0% over the year).
- Market cap
- $129.8M
- Enterprise value
- $119.4M
- Forward P/E
- -5.1
- EPS (trailing)
- $-0.16
- EPS (forward)
- $-0.20
- Payout ratio
- 0.0%
- 52-week range
- $0.87 – $2.35
- 52-week change
- -37.0%
- Beta
- 0.45
- Average volume
- 560,076
- Shares outstanding
- 127.3M
- Short % of float
- 4.67%
- Profit margin
- 0.0%
Fundamental figures are recorded once every few days, dated above; they are not live and can differ from the interactive tiles.
Last universe scan · 2026-09-09
In RapidTradeView’s 2026-09-09 scan of the US universe, Tiziana Life Sciences Ltd (TLSA) last closed at $0.99 (the last completed close before that scan).
Technicals at the scan: RSI 45 (neutral territory), price -5.7% versus its 20-day average, 20-day versus 50-day average spread -2.8%, MACD histogram -0.01.
Sentiment inputs: 100% of recent Finnhub-scored headlines read bullish; StockTwits 95% bullish.
Scan values are recorded once per trading day and are not live quotes; the interactive tiles above update in real time.
Smart Money · last 90 days
Members of Congress disclosed 0 buys and 0 sells of TLSA; corporate insiders filed 3 buys and 0 sells (1 filer, latest disclosure 2026-08-06). Filings arrive days to weeks after the trade and are not a live signal. Most active filers: Ivor Elrifi (3B/0S). Who is trading what
RapidTradeView pick record
TLSA has not appeared in the daily picks yet. Full scoreboard
What this page covers
RapidTradeView pulls Tiziana Life Sciences Ltd (TLSA) data from multiple independent sources and combines it into a single dashboard. Below the summary you’ll find live, interactive tiles for each of the following:
- Price & chart — real-time quote with pre/post-market moves and a line or candlestick chart.
- Technical indicators — RSI, MACD, moving averages, Bollinger Bands, volume and support/resistance, distilled into one overall signal.
- Analyst consensus — the buy/hold/sell breakdown and price targets published by Wall Street analysts.
- News sentiment — recent headlines, each scored for tone so the prevailing narrative is obvious.
- Earnings — current EPS, year-over-year change and the next scheduled earnings date.
- Social buzz — Reddit mention volume and StockTwits sentiment for the retail-trader angle.
How to read the signals
No single indicator tells the whole story. A bullish technical reading paired with a cautious analyst consensus, or strong social buzz against weak earnings, is exactly the kind of tension this view is built to surface. RapidTradeView’s signals are generated by deterministic, statistical models — they describe what the data is doing, they are not personalised recommendations to buy or sell TLSA.
Disclaimer: RapidTradeView is an educational sentiment-aggregation tool, not a licensed financial adviser, broker, or dealer. Nothing here is financial, investment, tax, or legal advice. Markets are risky and you can lose money. Always do your own research and consult a qualified professional before making any investment decision.